AnaptysBio Inc

General ticker "ANAB" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $592.7M

AnaptysBio Inc follows the US Stock Market performance with the rate: 22.5%.

Estimated limits based on current volatility of 2.8%: low 14.35$, high 15.64$

Factors to consider:

  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [11.64$, 24.68$]
  • 2024-12-30 to 2025-12-30 estimated range: [13.35$, 26.84$]

Financial Metrics affecting the ANAB estimates:

  • Negative: Non-GAAP EPS, $ of -6.08 <= 0.10
  • Negative: Operating cash flow per share per price, % of -20.60 <= 2.35
  • Negative: Operating profit margin, % of -90.55 <= 1.03
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85

Similar symbols

Short-term ANAB quotes

Long-term ANAB plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $63.17MM $10.29MM $17.16MM
Operating Expenses $119.99MM $125.44MM $181.57MM
Operating Income $-56.81MM $-115.15MM $-164.41MM
Non-Operating Income $-0.98MM $-13.55MM $0.79MM
Interest Expense $1.45MM $21.11MM $18.08MM
R&D Expense $98.50MM $88.80MM $132.28MM
Income(Loss) $-57.80MM $-128.70MM $-163.62MM
Taxes $0.00MM $0.02MM $-0.00MM
Profit(Loss) $-57.80MM $-128.72MM $-163.62MM
Stockholders Equity $356.43MM $262.10MM $88.10MM
Inventory $0.00MM $0.00MM $0.00MM
Assets $643.07MM $610.38MM $452.39MM
Operating Cash Flow $-45.92MM $-73.59MM $-120.80MM
Capital expenditure $1.37MM $0.36MM $0.81MM
Investing Cash Flow $38.84MM $-394.85MM $144.75MM
Financing Cash Flow $252.30MM $44.02MM $-59.30MM
Earnings Per Share* $-2.08 $-4.57 $-6.08

* EPS are Split Adjusted, recent splits may be reflected with a delay.